Regarding compliance and minimization of side effects of nilotinib therapy, there is a medical\nneed to have a gastroretentive drug delivery system (GRDDS) to enhance the oral bioavailability\nthat is able to administer an optimal dose in a quaque die (QD) or daily manner. In this study,\nthe influence on a swelling and floating (sf ) GRDDS composed of a polymeric excipient (HPMC 90SH\n100K, HEC 250HHX, or PEO 7000K) and Kollidon.................
Loading....